Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Anthony C. DeFranco"'
Autor:
Thomas F. Wilson, Muddasir Ashraf, M. Fuad Jan, Tonga Nfor, Louie Kostopoulos, Joaquin Solis, Jayant Khitha, Ahmad Khraisat, Anthony C. DeFranco, Tanvir Bajwa, Suhail Q. Allaqaband
Publikováno v:
Journal of Patient-Centered Research and Reviews, Vol 10, Iss 2, Pp 50-57 (2023)
Purpose: Dual antiplatelet therapy is standard for patients undergoing percutaneous coronary intervention (PCI) with stents. Traditionally, patients swallow the loading dose of a P2Y12 inhibitor before or during PCI. Time to achieve adequate platelet
Externí odkaz:
https://doaj.org/article/90a5c2785a1644a19c0d37b069a6f7c1
Autor:
Brian A. Baker, Samir Kapadia, Bimmer E. Claessen, Sameer Bansilal, Zhen Ge, Timothy Henry, Stuart J. Pocock, Roxana Mehran, Usman Baber, Sunil V. Rao, Craig Strauss, Stuart Keller, William S. Weintraub, Samantha Sartori, Kanhaiya L. Poddar, Clayton Snyder, Annapoorna Kini, Melissa Aquino, Birgit Vogel, Sandra Weiss, Catalin Toma, Brent Muhlestein, Mark B. Effron, Michela Faggioni, Anthony C. DeFranco, Jaya Chandrasekhar
Publikováno v:
Catheterization and Cardiovascular Interventions. 94:53-60
OBJECTIVE: To investigate the use of prasugrel after percutaneous coronary intervention (PCI) in African American (AA) patients presenting with acute coronary syndrome (ACS). BACKGROUND: AA patients are at higher risk for adverse cardiovascular outco
Autor:
Annapoorna Kini, Mark B. Effron, Samantha Sartori, Stuart J. Pocock, Sunil V. Rao, Craig Strauss, Michela Faggioni, Bimmer E. Claessen, Usman Baber, Samir R. Kapadia, Catalin Toma, Timothy D. Henry, William S. Weintraub, Jaya Chandrasekhar, Brian A. Baker, Anthony C. DeFranco, Stuart Keller, Roxana Mehran, Kanhaiya L. Poddar, Joseph B. Muhlestein, Clayton Snyder, Melissa Aquino, Serdar Farhan, Birgit Vogel, Sandra Weiss, Sabato Sorrentino
Publikováno v:
International Journal of Cardiology. 275:31-35
BACKGROUND: Clinical trial data studies suggest superiority of prasugrel over clopidogrel in patients with diabetes. However, the use, safety and efficacy profile of prasugrel in unselected diabetic patients presenting with acute coronary syndromes (
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome
Autor:
Bimmer E. Claessen, Roxana Mehran, Shawn X. Li, Sandra Weiss, Stuart Keller, Zhen Ge, Stuart J. Pocock, Brian A. Baker, George Dangas, Samir R. Kapadia, Timothy D. Henry, Jaya Chandrasekhar, Catalin Toma, Anthony C. DeFranco, Annapoorna Kini, Brent Muhlestein, Usman Baber, Mark B. Effron, Rishi Chandiramani, Sunil V. Rao, Craig Strauss, Samantha Sartori
Publikováno v:
Journal of thrombosis and thrombolysis, 48, 42-51. Springer Netherlands
We sought to investigate the utilization of prasugrel and its association with outcomes relative to clopidogrel in three typical subgroups of ACS in a real-world setting. Prasugrel is superior to clopidogrel for reducing risk of ischemic events in ac
Autor:
Zhen Ge, George Dangas, Stuart J. Pocock, Joseph B. Muhlestein, Catalin Toma, Samantha Sartori, Melissa Aquino, Samir R. Kapadia, Serdar Farhan, Brian A. Baker, Sunil V. Rao, Craig Strauss, Mark B. Effron, Jaya Chandrasekhar, Birgit Vogel, Sandra Weiss, Timothy D. Henry, Sabato Sorrentino, Stuart Keller, Anthony C. DeFranco, William S. Weintraub, Roxana Mehran, Usman Baber, Annapoorna Kini
Publikováno v:
Canadian Journal of Cardiology. 34:319-329
BACKGROUND: Potent P2Y12 inhibitors might offer enhanced benefit against thrombotic events in complex percutaneous coronary intervention (PCI). We examined prasugrel use and outcomes according to PCI complexity, as well as analyzing treatment effects
Autor:
Michela Faggioni, William S. Weintraub, Melissa Aquino, Serdar Farhan, Samantha Sartori, Brian A. Baker, Catalin Toma, Stuart Keller, Usman Baber, Timothy D. Henry, Mark B. Effron, George Dangas, Stuart J. Pocock, Roxana Mehran, Samir R. Kapadia, Anthony C. DeFranco, Sunil V. Rao, Craig Strauss, Jaya Chandrasekhar, Annapoorna Kini, Birgit Vogel, Sandra Weiss, Joseph B. Muhlestein
Publikováno v:
JACC: Cardiovascular Interventions. 10:2017-2025
Objectives This study sought to compare clinical outcomes in a contemporary acute coronary syndrome (ACS) percutaneous coronary intervention (PCI) cohort stratified by chronic kidney disease (CKD) status. Background Patients with CKD exhibit high ris
Autor:
Mark B. Effron, William S. Weintraub, Catalin Toma, Elizabeth Marrett, J. Brent Muhlestein, Sunil V. Rao, Craig Strauss, Usman Baber, Sameer Bansilal, Samir R. Kapadia, Stuart J. Pocock, Roxana Mehran, Kanhaiya L. Poddar, Stuart Keller, Sandra Weiss, Annapoorna Kini, Jaya Chandrasekhar, Brian A. Baker, Melissa Aquino, Timothy D. Henry, Anthony C. DeFranco, Samantha Sartori
Publikováno v:
American Heart Journal. 188:73-81
BACKGROUND AND OBJECTIVES: We sought to determine the frequency of use and association between prasugrel and outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention (PCI) in clinical practice. METHODS: PROMETHEUS wa
Autor:
Richard A. Kronmal, Shone Almeida, Lily Honoris, Anthony C. DeFranco, Dong Li, Steven C. Port, R. Graham Barr, Khurram Nasir, Matthew J. Budoff
Publikováno v:
JACC Cardiovasc Imaging
Coronary artery calcification (CAC) identifies atherosclerotic disease on electrocardiogram-gated computed tomography (CT) studies. However, nongated chest CTs may also have the capacity to accurately quantify coronary calcification. Although vascula
Autor:
Brian A. Baker, Kamilia Moalem, Catalin Toma, Bimmer E. Claessen, Zhen Ge, Jaya Chandrasekhar, Stuart J. Pocock, Mark B. Effron, Roxana Mehran, William S. Weintraub, Samir R. Kapadia, Joseph B. Muhlestein, Sunil V. Rao, Craig Strauss, Annapoorna Kini, Stuart Keller, Birgit Vogel, Sandra Weiss, Usman Baber, George Dangas, Melissa Aquino, Samantha Sartori, Timothy D. Henry, Anthony C. DeFranco
Publikováno v:
Clinical research in cardiology : official journal of the German Cardiac Society. 109(6)
Prasugrel is a potent thienopyridine that may be preferentially used in younger patients with lower bleeding risk.We compared prasugrel use and outcomes by age from the PROMETHEUS study. We also assessed age-related trends in treatment effects with p
Autor:
William S. Weintraub, Stuart J. Pocock, Rishi Chandiramani, Roxana Mehran, Catalin Toma, Davide Cao, Annapoorna Kini, Samir R. Kapadia, Mark B. Effron, Sabato Sorrentino, Joseph B. Muhlestein, Usman Baber, Shunsuke Aoi, Bimmer E. Claessen, Stuart Keller, Sunil V. Rao, Melissa Aquino, Brian A. Baker, Gennaro Giustino, Huazhen Chen, Timothy D. Henry, Anthony C. DeFranco, Samantha Sartori, Ridhima Goel
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 95(5)
BACKGROUND Stroke represents a potentially calamitous complication among patients with acute coronary syndrome (ACS) undergoing percutaneous intervention (PCI). Data on the distribution of stroke occurrence post-PCI and its impact on mortality are sc